{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:27:36Z","timestamp":1780590456730,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijcrp.2023.200168","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T02:19:58Z","timestamp":1673662798000},"page":"200168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ethnicity based differences in statin use and hypercholesterolemia control among patients with premature coronary artery disease-results of I-PAD study"],"prefix":"10.1016","volume":"16","author":[{"given":"Raheleh","family":"Karimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Zarepur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noushin","family":"Mohammadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoon","family":"Nouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Alikhasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Nasirian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Roohafza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Moezi Bady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Parisa janjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Solati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Lotfizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samad","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Javanmardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Gholipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mostafa dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Cheraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Assareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Haybar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Mahdieh","family":"Namayandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Reza madadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Kojuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3732-1516","authenticated-orcid":false,"given":"Marjan","family":"Mansourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijcrp.2023.200168_bib1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","article-title":"Demographic and epidemiologic drivers of global cardiovascular mortality","volume":"372","author":"Roth","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2023.200168_bib2","series-title":"Global Atlas on Cardiovascular Disease Prevention and Control","author":"Mendis","year":"2011"},{"issue":"2","key":"10.1016\/j.ijcrp.2023.200168_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0021-9150(94)90200-3","article-title":"Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European society of cardiology, European atherosclerosis society and European society of hypertension","volume":"110","author":"Py\u00f6r\u00e4l\u00e4","year":"1994","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ijcrp.2023.200168_bib4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00038-014-0602-6","article-title":"Hypertension: diagnosis, control status and its predictors in general population aged between 15 and 75 years: a community-based study in southeastern Iran","volume":"59","author":"Najafipour","year":"2014","journal-title":"Int. J. Publ. Health"},{"issue":"20","key":"10.1016\/j.ijcrp.2023.200168_bib5","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.1986.03380200061022","article-title":"Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?: findings in 356 222 primary screenees of the multiple risk factor intervention trial (mrfit)","volume":"256","author":"Stamler","year":"1986","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijcrp.2023.200168_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.1995.03530020049031","article-title":"Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty-five\u2014year follow-up of the seven countries study","volume":"274","author":"Verschuren","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijcrp.2023.200168_bib7","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"Grundy","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcrp.2023.200168_bib8","first-page":"833","article-title":"The Cholesterol Treatment Trialists'(CTT) Collaborators: efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"31","author":"Pendergrass","year":"2008","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ijcrp.2023.200168_bib9","first-page":"295","article-title":"Rationale, design, and preliminary results of the Iran-premature coronary artery disease study (I-PAD): a multi-center case-control study of different Iranian ethnicities","volume":"16","author":"Zarepur","year":"2020","journal-title":"ARYA atherosclerosis"},{"issue":"Suppl 1","key":"10.1016\/j.ijcrp.2023.200168_bib10","first-page":"S14","article-title":"Increased systemic exposure to rosuvastatin in Asian subjects residing in the United States compared to Caucasian subjects","volume":"83","author":"Kim","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.ijcrp.2023.200168_bib11","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1185\/03007990802312807","article-title":"Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia","volume":"24","author":"Tzeng","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"issue":"12","key":"10.1016\/j.ijcrp.2023.200168_bib12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.7164\/antibiotics.29.1346","article-title":"ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium","volume":"29","author":"Endo","year":"1976","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"2","key":"10.1016\/j.ijcrp.2023.200168_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-5793(76)80996-9","article-title":"Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity","volume":"72","author":"Endo","year":"1976","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.ijcrp.2023.200168_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jsha.2014.09.004","article-title":"Primary prevention with statins in cardiovascular diseases: a Saudi Arabian perspective","volume":"27","author":"Mahmood","year":"2015","journal-title":"J Saudi Heart Assoc"},{"issue":"1","key":"10.1016\/j.ijcrp.2023.200168_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5551\/jat.RV16004","article-title":"Racial differences in the cholesterol-lowering effect of statin","volume":"24","author":"Naito","year":"2017","journal-title":"J. Atherosclerosis Thromb."},{"issue":"9542","key":"10.1016\/j.ijcrp.2023.200168_bib16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijcrp.2023.200168_bib17","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1253\/circj.CJ-17-0811","article-title":"Treatment patterns, statin intolerance, and subsequent cardiovascular events among Japanese patients with high cardiovascular risk initiating statin therapy","volume":"82","author":"Nagar","year":"2018","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.ijcrp.2023.200168_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clpt.2005.06.013","article-title":"Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment","volume":"78","author":"Lee","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ijcrp.2023.200168_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/clpt.2012.221","article-title":"Ethnic variability in the plasma exposures of OATP1B1 substrates such as HMG-CoA reductase inhibitors: a kinetic consideration of its mechanism","volume":"94","author":"Tomita","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ijcrp.2023.200168_bib20","first-page":"137","article-title":"[Evaluation of statin use on LDL cholesterol levels in Turkey: a systematic review]","volume":"48","author":"K\u0131z\u0131l\u0131rmak","year":"2020","journal-title":"Turk Kardiyol. Dernegi Arsivi"},{"issue":"1","key":"10.1016\/j.ijcrp.2023.200168_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12911-020-01304-w","article-title":"Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease","volume":"20","author":"Saadati","year":"2020","journal-title":"BMC Med. Inf. Decis. Making"},{"issue":"5","key":"10.1016\/j.ijcrp.2023.200168_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/17425255.2.5.651","article-title":"Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy","volume":"2","author":"Ieiri","year":"2006","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"8","key":"10.1016\/j.ijcrp.2023.200168_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy--a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.ijcrp.2023.200168_bib24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2009.04.053","article-title":"The SLCO1B1*5 genetic variant is associated with statin-induced side effects","volume":"54","author":"Voora","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2023.200168_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03190142","article-title":"Sex difference in metabolism of simvastatin by rat hepatic microsomes","volume":"17","author":"Ohtawa","year":"1992","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ijcrp.2023.200168_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1248\/cpb.39.236","article-title":"Male-specific metabolism of simvastatin by rat liver microsomes","volume":"39","author":"Uchiyama","year":"1991","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"6","key":"10.1016\/j.ijcrp.2023.200168_bib27","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.2337\/diabetes.51.6.1708","article-title":"Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities","volume":"51","author":"Waterman","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcrp.2023.200168_bib28","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1100\/tsw.2003.121","article-title":"Differences between lovastatin and simvastatin hydrolysis in healthy male and female volunteers:gut hydrolysis of lovastatin is twice that of simvastatin","volume":"3","author":"Vree","year":"2003","journal-title":"Sci. World J."},{"issue":"1","key":"10.1016\/j.ijcrp.2023.200168_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0021-9150(94)90064-7","article-title":"Gender and diet interactions with simvastatin treatment","volume":"110","author":"Clifton","year":"1994","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ijcrp.2023.200168_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","article-title":"Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences","volume":"32","author":"Lennern\u00e4s","year":"1997","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ijcrp.2023.200168_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00129784-200404040-00005","article-title":"Genetic polymorphisms in cytochrome P450 enzymes: effect on efficacy and tolerability of HMG-CoA reductase inhibitors","volume":"4","author":"Vermes","year":"2004","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"4","key":"10.1016\/j.ijcrp.2023.200168_bib32","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.1840380424","article-title":"Sex is a major determinant of CYP3A4 expression in human liver","volume":"38","author":"Wolbold","year":"2003","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.ijcrp.2023.200168_bib33","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.ijcrp.2023.200168_bib34","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ijcrp.2023.200168_bib35","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1001\/jama.291.23.2821","article-title":"Pharmacogenetic study of statin therapy and cholesterol reduction","volume":"291","author":"Chasman","year":"2004","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ijcrp.2023.200168_bib36","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1001\/jama.291.23.2821","article-title":"Pharmacogenetic study of statin therapy and cholesterol reduction","volume":"291","author":"Chasman","year":"2004","journal-title":"JAMA"}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487523000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487523000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:57:11Z","timestamp":1757415431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487523000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":36,"alternative-id":["S2772487523000016"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2023.200168","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethnicity based differences in statin use and hypercholesterolemia control among patients with premature coronary artery disease-results of I-PAD study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2023.200168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200168"}}